---
title: "12 Health Care Stocks Moving In Thursday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277095170.md"
description: "In Thursday's after-market session, several health care stocks experienced notable movements. Gainers included Kairos Pharma (AMEX:KAPA) with an 11.3% rise to $0.61, Neurogene (NASDAQ:NGNE) up 6.7% to $21.0, and PharmaCyte Biotech (NASDAQ:PMCB) increasing 6.53% to $0.75. Conversely, BioLine Rx (NASDAQ:BLRX) saw an 11.0% decline to $2.56, while Cypherpunk Technologies (NASDAQ:CYPH) fell 9.15% to $0.63. Dentsply Sirona (NASDAQ:XRAY) dropped 5.98% to $11.95, and Progyny (NASDAQ:PGNY) decreased 5.62% to $21.0 following Q4 earnings announcements."
datetime: "2026-02-26T21:05:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277095170.md)
  - [en](https://longbridge.com/en/news/277095170.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277095170.md)
---

# 12 Health Care Stocks Moving In Thursday's After-Market Session

### Gainers

-   **Kairos Pharma** (AMEX:KAPA) stock rose 11.3% to $0.61 during Thursday's after-market session. The market value of their outstanding shares is at $13.0 million.
-   **Neurogene** (NASDAQ:NGNE) shares increased by 6.7% to $21.0. The market value of their outstanding shares is at $311.1 million.
-   **PharmaCyte Biotech** (NASDAQ:PMCB) shares moved upwards by 6.53% to $0.75. The company's market cap stands at $7.3 million.
-   **Curanex Pharmaceuticals** (NASDAQ:CURX) stock moved upwards by 6.32% to $0.49. The market value of their outstanding shares is at $8.9 million.
-   **Cue Biopharma** (NASDAQ:CUE) shares rose 4.16% to $0.3. The company's market cap stands at $25.8 million.
-   **bioAffinity Technologies** (NASDAQ:BIAF) stock rose 3.84% to $1.08. The market value of their outstanding shares is at $4.9 million.

### Losers

-   **BioLine Rx** (NASDAQ:BLRX) shares decreased by 11.0% to $2.56 during Thursday's after-market session. The market value of their outstanding shares is at $10.2 million.
-   **Cypherpunk Technologies** (NASDAQ:CYPH) shares declined by 9.15% to $0.63. The market value of their outstanding shares is at $38.8 million.
-   **VSee Health** (NASDAQ:VSEE) shares decreased by 7.14% to $0.35. The market value of their outstanding shares is at $13.9 million.
-   **Vivos Therapeutics** (NASDAQ:VVOS) shares fell 6.21% to $1.36. The market value of their outstanding shares is at $16.7 million.
-   **Dentsply Sirona** (NASDAQ:XRAY) shares declined by 5.98% to $11.95. The company's market cap stands at $2.5 billion. As per the press release, Q4 earnings came out today.
-   **Progyny** (NASDAQ:PGNY) shares declined by 5.62% to $21.0. The market value of their outstanding shares is at $1.8 billion. The company's, Q4 earnings came out today. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [PMCB.US](https://longbridge.com/en/quote/PMCB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [KAPA.US](https://longbridge.com/en/quote/KAPA.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [NGNE.US](https://longbridge.com/en/quote/NGNE.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PGNY.US](https://longbridge.com/en/quote/PGNY.US.md)
- [BLRX.US](https://longbridge.com/en/quote/BLRX.US.md)

## Related News & Research

- [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md)
- [Guotai Asset Management sees liquidity boost driving China biotech, innovation drug shares higher](https://longbridge.com/en/news/296448906.md)
- [Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook](https://longbridge.com/en/news/296021831.md)
- [LIVE MARKETS-BofA clients flock to tech stocks](https://longbridge.com/en/news/296383193.md)
- [U.S. kindergarten vaccine coverage falls, CDC says](https://longbridge.com/en/news/296136711.md)